AI group improved from 12.2 to 3.4 by Week 12, while controls stayed at 10.0 (p<.001).
AI group dropped from 10.4 to 1.9 by Week 12, compared to controls at 9.2 (p<.001)
AI group’s scores rose from 62.3 to 91.1, while controls declined to 56.2 (p<.001).
— Lynia Huang, Founder of Here Hear AI


Talk to your AI companion anytime, anywhere.

Reduce stress, sleep better, feel supported.
Here Hear offers a clinically validated digital solution designed to integrate seamlessly into oncology care programs.
By delivering structured support between clinical visits, we help reduce emotional burden, lower risk of ER visits and readmissions, and enhance patient adherence to treatment plans.
For payors and health systems, this translates into a cost-effective, scalable intervention that complements existing care pathways.

